Changes in Manufacturing Processes of Biologic Therapies Can Alter the Immunogenicity Profile of the Product
Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1694
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 11, 2019
Authors
Publisher
Wiley